Hepatitis C Treatments Viekira Pak and Technivie: Drug Safety Communication - Risk of Serious Liver Injury
Cases of hepatic decompensation and liver failure in patients with underlying liver cirrhosis who were taking these medicines.
Italiano
Cases of hepatic decompensation and liver failure in patients with underlying liver cirrhosis who were taking these medicines.
Prescribers and patients should consider separating Kayexalate dosing from other medications taken by mouth by at least 6 hours.
If there is a contamination in products intended to be sterile, patients are at risk of serious infections which may be life threatening.
L'Agenzia Italiana del Farmaco rende disponibili nuove e importanti
informazioni, concordate con l'Agenzia Europea dei Medicinali, riguardo il potenziamento della radiotossicità associata a Zelboraf (vemurafenib).
Potential for contaminated water to transmit bacteria through the air (aerosolize) through the device’s exhaust vent into the environment and to the patient.
If the product is taken at the maximum labeled dose, or with other medications containing acetaminophen, it may lead to liver toxicity or liver failure.
80.211.154.110